HIKAL - Hikal | Wealthrox

Hikal

HIKAL · Pharma > Pharmaceuticals & Drugs · Chairman: Jai Hiremath · MD: Jai Hiremath · Listing date: Feb. 15, 2001 · Employees: 1528 · Navi Mumbai · http://www.hikal.com

Stock Price vs Company Growth

0.8%

4.3%

6.2%

1.8%

32.5%

38.8%

8.8%

10y

9.4%

all

10.0%

🤔 How to analyze this graph?

Last Traded Price

₹ 253 0.8%

217

283

Company Overview

Sales

1,699 Cr

Growth: -0.5%

Profit after Tax

10.1 Cr

Growth: -84.0%

Small Cap

3,117 Cr

P/E: 312.1x

Industry P/E: 33.1x

Fundamentals

Sales (Cr)	₹ 1,699
Growth	-0.5%
EBITDA	13.4%
P/S	1.8x
Dividend	0.3%
P/E	312.1x
Book Value	₹ 97.7
PEG Ratio	-576.1x
ROE	0.8%
P/B	2.6x

Shareholding Pattern

Institutions

Government Pension Fund Global

2.31 %

Promoters

Kalyani Investment Company Limited

31.36 %

Shri Badrinath Investment Pvt Ltd

16.15 %

Shri Rameshwara Investment Pvt Ltd

7.96 %

Sugandha Jai Hiremath

7.84 %

Bf Investment Limited

2.65 %

Others

Si Investments And Broking Private Limited

1.62 %

Llp

0.4 %

Iepf

0.21 %

Increase Decrease No change

Company Profile Detailed

Established in 1988 Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner. Their advanced infrastructure has been inspected and approved by globally recognized bodies such as the USFDA. Hikal is a company built on enduring relationships.

Belongs to (10 Indices) view more

Investors (62)

internat...

ritu.aru...

idfc.ste...

Followers (6)

mike2

nitin29

vishal48